Академический Документы
Профессиональный Документы
Культура Документы
Any information contained in this pdf file is automatically generated from digital material
submitted to EPOS by third parties in the form of scientific presentations. References
to any names, marks, products, or services of third parties or hypertext links to third-
party sites or information are provided solely as a convenience to you and do not in
any way constitute or imply ECR's endorsement, sponsorship or recommendation of the
third party, information, product or service. ECR is not responsible for the content of
these pages and does not make any representations regarding the content or accuracy
of material in this file.
As per copyright regulations, any unauthorised use of the material or parts thereof as
well as commercial reproduction or multiple distribution by any traditional or electronically
based reproduction/publication method ist strictly prohibited.
You agree to defend, indemnify, and hold ECR harmless from and against any and all
claims, damages, costs, and expenses, including attorneys' fees, arising from or related
to your use of these pages.
Please note: Links to movies, ppt slideshows and any other multimedia files are not
available in the pdf version of presentations.
www.myESR.org
Page 1 of 8
Aims and objectives
On standard T2 weighted MR images, since both hepatic hemangiomas and cysts are
typically hyperintense, the differentiation between these benign lesions cannot be made
unless intravenous gadolinium is administered. On the other hand, if an appropriate null
point is chosen, the signal of hepatic hemangiomas will be suppressed, but cysts will
continue to appear hyperintense.
In this study, the additive diagnostic value of "inversion recovery" single-shot fast spin-
echo (IR-SSFSE) sequence using the inversion time (TI) of hepatic hemangioma as a
supplement to standard T2 weighted MR imaging for the differentiation of hemangiomas
and cysts is evaluated.
A total of 130 lesions (82 hemangiomas, 48 cysts) were evaluated in this study. The study
population consisted of 14 males and 19 females (total 33 patients) aged between 29-78
years (mean 50 years). The study was performed on 1.5 T MR unit using 12-channel
body coil. In addition to routine hepatic MR imaging, IR-SSFSE imaging using TI value
of 600 ms (null point for hepatic hemangiomas) was taken. The parameters of sequence
are shown in table 1.
Page 2 of 8
Image Analysis
The segments of the liver were reviewed on T2 weighted images, and the lesions which
were "significantly hyperintense" were recorded. Afterwards, the signal alteration of these
hyperintense lesions was evaluated on IR-SSFSE sequence and the lesions were scored
using a five-point scale independently by two radiologists (1= definitely hemangioma, 2=
probably hemangioma, 3= discrimination cannot be made (equivocal), 4= probably cyst,
5= definitely cyst) (Figures 1-3).
Page 3 of 8
Fig. 1: Axial T2W images (a,b) of a 57-year-old female patient show hyperintense lesions
in segment 7 (15 mm) and at the margin of segments 5-6 (6 mm) (arrows). On the IR-
SSFSE image (c,d), the lesion in segment 7 becomes hypointense compared with the
hepatic parenchyma (arrow), however, other lesion remains hyperintense, and in the
periphery of this lesion dark rim artifact is demonstrated (arrow in d). On postcontrast
images (e,d), the lesion in segment 7 is enhanced compatible with a hemangioma,
conversely, the cystic lesion does not show enhancement.
Page 4 of 8
Fig. 2: T2W images of 30-year-old male patient (a,b) indicate 18 mm and 5 mm
hyperintense lesions in segments 7 and 3, respectively (arrows). The lesion in segment
7 is hypointense, and the lesion in segment 3 is hyperintense on IR-SSFSE images
compared with the hepatic parenchyma (c,d). On dynamic contrast-enhanced MR
images (e,g) while the lesion in segment 7 shows "peripheral nodular" enhancement
(hemangioma), other lesion in segment 3 shows no enhancement (cyst).
Page 5 of 8
Results
When 3 scoring (1-3) was used, statistically significant interobserver correlation was
found as #=0.596; p<0.001.
In the ROC analysis for the differentiation of hepatic hemangiomas from cysts, AUC was
0.748 for the first observer, and was 0.867 for the second observer.
Page 6 of 8
Fig. 4: In the ROC analysis for the differentiation of hepatic hemangiomas from cysts,
AUC was 0.748 for the first observer, and was 0.867 for the second observer.
Page 7 of 8
Conclusion
Personal information
References
Page 8 of 8